Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery

Kayi Y Chan; Michael Baun; René de Vries; Antoon J van den Bogaerdt; Clemens M F Dirven; Alexander H J Danser; Inger Jansen-Olesen; Jes Olesen; Carlos M Villalón; Antoinette MaassenVanDenBrink; Saurabh Gupta

doi:http://dx.doi.org/10.1177/0333102410375624

Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery

Kayi Y Chan, Michael Baun, René de Vries, Antoon J van den Bogaerdt, Clemens M F Dirven, Alexander H J Danser, Inger Jansen-Olesen, Jes Olesen, Carlos M Villalón, Antoinette MaassenVanDenBrink, Saurabh Gupta

Research output: Contribution to journal › Journal article › Research › peer-review

68 Citations (Scopus)

Abstract

We pharmacologically characterized pituitary adenylate cyclase-activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC(1), VPAC(2) and PAC(1) receptors in human meningeal (for their role in migraine) and coronary (for potential side effects) arteries.

Original language	English
Journal	Cephalalgia
Volume	31
Issue number	2
Pages (from-to)	181-9
Number of pages	9
ISSN	0333-1024
DOIs	https://doi.org/10.1177/0333102410375624
Publication status	Published - 2011

Access to Document

http://dx.doi.org/10.1177/0333102410375624

Cite this

Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. / Chan, Kayi Y; Baun, Michael; de Vries, René; van den Bogaerdt, Antoon J; Dirven, Clemens M F; Danser, Alexander H J; Jansen-Olesen, Inger; Olesen, Jes; Villalón, Carlos M; MaassenVanDenBrink, Antoinette; Gupta, Saurabh.

In: Cephalalgia, Vol. 31, No. 2, 2011, p. 181-9.

Research output: Contribution to journal › Journal article › Research › peer-review

Chan, Kayi Y ; Baun, Michael ; de Vries, René ; van den Bogaerdt, Antoon J ; Dirven, Clemens M F ; Danser, Alexander H J ; Jansen-Olesen, Inger ; Olesen, Jes ; Villalón, Carlos M ; MaassenVanDenBrink, Antoinette ; Gupta, Saurabh. / Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. In: Cephalalgia. 2011 ; Vol. 31, No. 2. pp. 181-9.

@article{fc7e502e5f3b4fad9896e6312102743c,

title = "Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery",

abstract = "We pharmacologically characterized pituitary adenylate cyclase-activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC(1), VPAC(2) and PAC(1) receptors in human meningeal (for their role in migraine) and coronary (for potential side effects) arteries.",

author = "Chan, {Kayi Y} and Michael Baun and {de Vries}, Ren{\'e} and {van den Bogaerdt}, {Antoon J} and Dirven, {Clemens M F} and Danser, {Alexander H J} and Inger Jansen-Olesen and Jes Olesen and Villal{\'o}n, {Carlos M} and Antoinette MaassenVanDenBrink and Saurabh Gupta",

year = "2011",

doi = "http://dx.doi.org/10.1177/0333102410375624",

language = "English",

volume = "31",

pages = "181--9",

journal = "Cephalalgia",

issn = "0800-1952",

publisher = "SAGE Publications",

number = "2",

}

TY - JOUR

T1 - Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery

AU - Chan, Kayi Y

AU - Baun, Michael

AU - de Vries, René

AU - van den Bogaerdt, Antoon J

AU - Dirven, Clemens M F

AU - Danser, Alexander H J

AU - Jansen-Olesen, Inger

AU - Olesen, Jes

AU - Villalón, Carlos M

AU - MaassenVanDenBrink, Antoinette

AU - Gupta, Saurabh

PY - 2011

Y1 - 2011

N2 - We pharmacologically characterized pituitary adenylate cyclase-activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC(1), VPAC(2) and PAC(1) receptors in human meningeal (for their role in migraine) and coronary (for potential side effects) arteries.

AB - We pharmacologically characterized pituitary adenylate cyclase-activating polypeptides (PACAPs), vasoactive intestinal peptide (VIP) and the VPAC(1), VPAC(2) and PAC(1) receptors in human meningeal (for their role in migraine) and coronary (for potential side effects) arteries.

U2 - http://dx.doi.org/10.1177/0333102410375624

DO - http://dx.doi.org/10.1177/0333102410375624

M3 - Journal article

VL - 31

SP - 181

EP - 189

JO - Cephalalgia

JF - Cephalalgia

SN - 0800-1952

IS - 2

ER -